anthera logo

Press Releases

All Releases
View Summary Anthera Pharmaceuticals Announces Update on Strategic Partnership Discussions for Blisibimod
Oct 1, 2014
PDF 10.7 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update
Jul 28, 2014
PDF 18.9 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Announces Acquisition of Sollpura® (liprotamase) for Exocrine Pancreatic Insufficiency From Eli Lilly and Company
Jul 14, 2014
PDF 14.6 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Appoints Brian R. Mueller to Board of Directors
Jun 23, 2014
PDF 10.9 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Appoints Dr. Philip Sager to Board of Directors
Jun 13, 2014
PDF 11.4 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Reports 2014 First Quarter Financial Results and Operational Update
May 13, 2014
PDF 21.4 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Announces Personnel Changes
Mar 31, 2014
PDF 11.3 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Reports 2013 Fourth Quarter And Fiscal Year Financial Results and Operational Update
Mar 12, 2014
PDF 24.0 KB Add to Briefcase
View Summary Anthera Pharmaceuticals to Present at Leerink Swann, Cowen & Co., and BIO CEO Healthcare Conferences
Jan 30, 2014
PDF 11.8 KB Add to Briefcase
View Summary Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference
Nov 27, 2013
PDF 10.6 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update
Oct 29, 2013
PDF 18.6 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting
Sep 25, 2013
PDF 13.8 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results
Jul 30, 2013
PDF 18.6 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock
Jul 12, 2013
PDF 11.9 KB Add to Briefcase
View Summary Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod
Jun 24, 2013
PDF 12.3 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice
Jun 21, 2013
PDF 10.5 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Announces Personnel Changes
Jun 12, 2013
PDF 11.5 KB Add to Briefcase
View Summary Anthera Pharmaceuticals to Present at Annual Jefferies Healthcare Conference
May 31, 2013
PDF 10.9 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
May 13, 2013
PDF 17.1 KB Add to Briefcase
View Summary Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
May 7, 2013
PDF 14.5 KB Add to Briefcase
Showing 1-20 of 129 Page: 1 2 3 ... 7  Next 20
=add release to Briefcase
Back to Top

© 2014 Anthera Pharmaceuticals, Inc., All Rights Reserved.